Deconstructing the Biosimilar Promise: Can Industry Deliver on Access and Affordability?

It is widely accepted that biosimilars hold the potential to improve patient access to life-changing therapies. However, questions remain about what will be needed to deliver on the promise of greater biosimilar access and affordability. In a recent panel discussion, industry experts weighed in on the state of the biosimilar market, today’s regulatory climate, and what will be required to realize their potential.

Empowering Precision Medicine: Transforming Clinical Trials with Precision-Based Solutions

Precision medicine has emerged as a game-changer, revolutionizing the landscape of clinical trials and offering new hope for advancement of critical medicines. However, the intricate nature of precision medicine requires precision-based solutions for trial sponsors, clinical research organizations, labs, and research sites. To address the most pressing issues, trial sponsors and research sites must pivot toward precision-based solutions.

Harmony of Mind, Body, and Spirit: Fostering Clinical Project Managers’ Spiritual Growth and Well-Being

Clinical project managers face a range of well-being issues that are unique to their field. These challenges stem from the high-pressure nature of the pharmaceutical and clinical research industry, where the stakes are often very high, and the work can be both demanding and complex. One path forward offers opportunities to find balance and well-being, bringing together the mind, body, and spirit.
Elisa Cascade

A Q&A with Elisa Cascade: Chair, 2024 ACRP Board of Trustees

As Elisa Cascade, MBA, Chief Product Officer for Advarra, begins her volunteer duties as the 2024 Chair of the Association Board of Trustees (ABoT) for ACRP, she took time to answer some questions about her experience in the clinical research enterprise, some of the challenges facing it, and how ACRP can help to address them.